Full seating capacity at Delhi cinema halls, 200 people allowed at weddings, funerals

HomeNewsTrendsHealth

Full seating capacity at Delhi cinema halls, 200 people allowed at weddings, funerals

(Eds: With more info) New Delhi, Oct 29 The Delhi Disaster Management Authority (DDMA) on Friday issued an order allowing full-seating capacity in ci..

PTI

October 29, 2021 / 08:06 PM IST

The Delhi Disaster Management Authority (DDMA) on Friday issued an order allowing full-seating capacity in cinema halls, theatres and multiplexes, and also raised the number of people allowed to attend weddings and last rites from 100 to 200.

The order, listing various allowed and restricted activities because of the COVID pandemic, will come into effect from November 1.

It stated that owners of cinema halls, theatres and multiplexes will be responsible for strict adherence to standard operating protocol (SOP), official guidelines and COVID-appropriate behaviour at the premises.

"In case any violation is found, strict penal, criminal action shall be taken against the owner of the restaurant, bar, cinemas, theatres and multiplexes,” said the order.

Cinemas, theatres, multiplexes in the city were closed with the imposition of lockdown in April amid a raging second wave of COVID infections.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show